Fertility centers and cell-free fetal dna screening (cffdna): a review of maternit ® 21 plus performance in the reproductive health setting

Individuals who become pregnant through reproductive endocrinology and infertility (REI) often conceive by some type of fertility treatment. Patients who have experienced infertility or received fertility treatment, may have an aversion to chorionic villus sampling or amniocentesis because of the perceived risk associated with these procedures. Given the risk of procedure related pregnancy loss from these procedures patients may request cffDNA to provide additional information prior to deciding on diagnostic testing.

Source: Fertility and Sterility - September 1, 2021 Category: Reproduction Medicine Authors: Vanessa Nitibhon, Brittany Dyr, Kimberly Ann Fanelli, Jill Rafalko Source Type: research